EN 中文

Homepage>News and Information>Company news

Pride! Shanghai Jahwa has used 2021 Nobel Prize achievements to establish sting evaluation method

2021-11-16

Last month, the 2021 Nobel Prize winners were announced. Among them, the Physiology or Medicine Prize was won by American scientists David Julius and Arden Pataputian. The two science prizes were awarded for the discovery of pain/temperature receptors and tactile receptors in the fields of sensing temperature and touch. The official Nobel Prize commented: "Our ability to perceive heat, cold and touch is essential for survival and the basis for our interaction with the world around us. However, how are human nerve impulses activated to sense temperature and pressure? This year's Nobel Laureates have addressed this problem."

As one of the most prestigious medical research awards in the world, the Nobel Prizes in Physiology or Medicine over the years have always demonstrated the major achievements of a century of medical development. In June this year, the Shanghai Jahwa Science and Technology Innovation Center published an academic paper entitled "Construction of TRPV1 Receptor Stable Transduced Cell Lines and Evaluation of Cosmetic Raw Materials Pain" in the "Journal of Toxicology", a comprehensive academic journal of toxicology in China. Stated in the text: This study is of great significance for the safety assessment of cosmetic products and raw materials, and the further improvement of cosmetic mildness.

Recently, the company's infant care brand Qichu has applied the Nobel Prize pain receptor TRPV1 mechanism in product development. At the same time, through the combination of conventional acute eye irritation tests, a more comprehensive evaluation of the product is carried out, and continuous efforts are made to create a milder and safer product for infants and young children. This demonstrates that Shanghai Jahwa has an international scientific research level and strength, and its independent research and development capabilities are at the leading level in China.

Shanghai Jahwa Science and Technology Innovation Center is a national-level enterprise technology center, a national-level industrial design center, and a post-doctoral research station. It has established three key scientific research points: consumer demand, multi-platform technology, and project whole-process management. At the same time, it has eight basic platforms for safety evaluation, efficacy screening, packaging design, medical transformation, Chinese medicine research and development, cell biology, AI customization, and beauty equipment. It has also established an open scientific research network, including 7 contracted experts, 13 testing centers and 14 research institutions.

The company invests more than 100 million yuan in research and development every year to support the research and development and creation of ingenious products. In the second quarter of this year, Shanghai Jahwa became the first local company in China to establish a technological innovation partnership with BASF, the world's leading chemical company, in the fields of beauty and personal care. In the future, the company will use internal and external R&D strength and technological means to accelerate the digital transformation and transformation of scientific research, and continue to empower the brand with technology, so as to continuously bring more innovative and diversified products and experiences to consumers.

A century of ingenuity, the pursuit of perfection. In the future, the company will continue to stay true to its original aspiration, pursue the most beautiful products and services with perfection, create maximum value for consumers, employees, shareholders and society, and strive to become a leader in China's beauty and daily chemical industry, and to bring China Beauty to the forefront. to the world.